Using a unique injury model of the pancreas in mouse, Xu et al. (2008) now reveal the involvement of neurogenin3, a marker for embryonic-type endocrine progenitor cells, in the formation of new insulin-producing β cells. These neurogenin3-positive facultative endocrine progenitor cells in the adult pancreas may be of potential value for treating diabetes.
A major challenge of modern biology is to identify the cellular origins of tissues, an effort that has important implications for the treatment of neoplastic and degenerative diseases. In the case of the pancreas, understanding how insulin-producing β cells are generated may aid in the design of regenerative and cellular therapies for type 1 and type 2 diabetes, diseases characterized by loss or insufficient numbers of β cells (Halban, 2004) . During embryonic development of the pancreas, β cells are generated from a transient population of endocrine progenitor cells expressing the transcription factor neurogenin3 (ngn3) (Gu et al., 2002; Murtaugh, 2007) . However, during postnatal life, ngn3-positive progenitor cells disappear, and β cell expansion and maintenance relies on the proliferation of terminally differentiated β cells. This mode of maintenance and repair has been demonstrated during normal adult homeostasis as well as during β cell regeneration induced by either partial removal of the pancreas or specific ablation of β cells (Dor et al., 2004; Lee et al., 2006; Teta et al., 2007; Brennand et al., 2007; Nir et al., 2007) . Together, these data suggested that the principal "natural" mode of β cell replacement in adult mammals requires pre-existing β cells.
In this issue of Cell, Xu, Heimberg, and colleagues now report an important exception with their demonstration that β cells in adult mice can be formed from non-β cells (Xu et al., 2008) . In convincing experiments, they make use of a unique model of tissue damage and discover that cells expressing ngn3 reappear in adult mice following injury and give rise to new β cells. This study provides a clear example that facultative β cell progenitors exist, and suggests that the adult pancreas contains cells that retain the potential to revert to an embryonic-type mode of β cell generation.
Xu et al. examined in detail the consequences of partial duct ligation, a surgical procedure in which drainage of digestive enzymes from the exocrine pancreas into the duodenum is restricted, causing widespread degeneration of acinar cells and extensive proliferation of remaining ducts. As observed by Rosenberg, Duguid, and Vinik who developed a similar model in the 1980s, duct ligation results in hyperplasia of the islets of Langerhans, the structures in the pancreas in which β cells reside (Rosenberg, 1998) . A key finding of Xu et al. is that in the days that follow partial duct ligation, ngn3 expression is induced in the pancreas. To determine if these ngn3-positive cells can give rise to new β cells, ngn3-positive cells were isolated from the injured mouse pancreas by flow cytometry and injected into an explanted embryonic pancreas. Pancreatic buds from ngn3-deficient embryos were used as recipients for the sorted ngn3-positive cells, because endogenous endocrine cells fail to develop without ngn3. Their data convincingly show that ngn3-positive cells isolated from adult mice after partial duct ligation differentiate into β cells and other pancreatic hormone-producing cells in the explanted embryonic pancreas. Thus, in addition to proliferation of pre-existing β cells, the appearance and subsequent differentiation of ngn3-positive cells also contributes to new β cells after this type of injury.
The authors also attempted to determine the importance of ngn3 expression for islet hyperplasia (and concurrent β-cell production) after partial duct ligation in adult mice. In vivo infection of the adult mouse pancreas with lentiviruses containing short hairpin RNA molecules directed against ngn3 reduced islet hyperplasia. This suggested that ngn3 plays an important role in the generation of new β cells in the adult following partial duct ligation, similar to its role during embryonic development. Proving this notion awaits an adultonset knockout of the ngn3 gene using Cre-lox technology. Finally, expression studies and lineage tracing led the authors to conclude that ngn3-positive cells emerge from the pancreatic ducts (Bonner-Weir et al., 2004) . Definitive identification of the cell type that turns on the ngn3 gene in the adult pancreas and determining the precise anatomical niche controlling this event are important future challenges.
What are the implications of this study? First, it reveals that the adult pancreas retains the potential to reactivate its embryonic mode of β cell formation. It will be important to determine which source of cells offers the greater potential for producing new β cells: replication of pre-existing β cells or differentiation of these newly discovered adult ngn3-positive cells. In this regard, the pancreas looks more like the liver, which normally regenerates from injury (such as partial hepatectomy) by simple proliferation of hepatocytes, but following specific types of insults is thought to activate "facultative" stem cells known as oval cells. The provocative suggestion that follows from the current work is that patients with type 1 diabetes, which have lost the vast majority of their β cells, may still retain a population of cells capable of producing new β cells.
Naturally, this study raises multiple questions. For example, we do not know what induces the reversal of the pancreas to an embryonic mode of endocrine development. Identifying molecules that trigger this response following partial duct ligation and potentially other injury models, will provide a key missing link between tissue injury and repair. In this regard, it will be interesting to determine whether islet neogenesis-associated protein (INGAP) induces ngn3 expression. INGAP was identified in previous studies using duct ligation and is proposed to mediate the formation of new β cells (Rosenberg, 1998) . The biology of adult ngn3-positive cells also remains mysterious. Do they migrate to join existing islets? How extensively do ngn3-positive cells or their progeny proliferate? Finally, the therapeutic relevance of these findings will have to be determined. Do ngn3-positive cells exist in patients with diabetes, and are there sufficient numbers to have a physiological effect? Does the adult human pancreas retain the potential to reactivate an embryonic-type endocrine progenitor pathway in vivo or in vitro? In this respect, the development of new methods to study the dynamics of the postnatal pancreas in humans, such as non invasive imaging and lineage tracing, is likely to be rewarding.
